NYSE:ASRT - Depomed News Headlines

$1.40
-0.12 (-7.89 %)
(As of 08/23/2019 04:00 PM ET)
Today's Range
$1.3726
Now: $1.40
$1.55
50-Day Range
$1.30
MA: $2.65
$3.50
52-Week Range
$1.27
Now: $1.40
$7.43
Volume980,258 shs
Average Volume979,634 shs
Market Capitalization$90.76 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Depomed (NYSE ASRT) News Headlines

Source:
DateHeadline
 Analysts Anticipate Depomed, Inc. (NYSE:ASRT) Will Post Earnings of $0.23 Per Share Analysts Anticipate Depomed, Inc. (NYSE:ASRT) Will Post Earnings of $0.23 Per Share
www.americanbankingnews.com - August 23 at 6:15 AM
Insider Buying: Depomed, Inc. (NYSE:ASRT) CFO Buys 14,000 Shares of StockInsider Buying: Depomed, Inc. (NYSE:ASRT) CFO Buys 14,000 Shares of Stock
www.americanbankingnews.com - August 20 at 6:15 PM
Insider Buying: Depomed, Inc. (NYSE:ASRT) Director Buys 25,000 Shares of StockInsider Buying: Depomed, Inc. (NYSE:ASRT) Director Buys 25,000 Shares of Stock
www.americanbankingnews.com - August 20 at 6:15 PM
ASRT vs. PCRX: Which Stock Is the Better Value Option?ASRT vs. PCRX: Which Stock Is the Better Value Option?
finance.yahoo.com - August 19 at 11:39 AM
Assertio Therapeutics Inc (ASRT) Director, President and CEO Arthur J Higgins Bought $77,000 of ...Assertio Therapeutics Inc (ASRT) Director, President and CEO Arthur J Higgins Bought $77,000 of ...
finance.yahoo.com - August 12 at 10:21 PM
Insider Buying: Depomed, Inc. (NYSE:ASRT) CFO Acquires 19,000 Shares of StockInsider Buying: Depomed, Inc. (NYSE:ASRT) CFO Acquires 19,000 Shares of Stock
www.americanbankingnews.com - August 12 at 9:02 PM
Arthur J. Higgins Purchases 50,000 Shares of Depomed, Inc. (NYSE:ASRT) StockArthur J. Higgins Purchases 50,000 Shares of Depomed, Inc. (NYSE:ASRT) Stock
www.americanbankingnews.com - August 12 at 8:59 PM
Assertio Therapeutics Announces Exchange Offer of $200 Million of its Currently Outstanding 2.50% Convertible Notes Due 2021Assertio Therapeutics Announces Exchange Offer of $200 Million of its Currently Outstanding 2.50% Convertible Notes Due 2021
finance.yahoo.com - August 9 at 11:32 AM
Assertio (ASRT) Q2 Earnings Beat EstimatesAssertio (ASRT) Q2 Earnings Beat Estimates
finance.yahoo.com - August 7 at 11:30 PM
Assertio Therapeutics Announces Strong Second-Quarter 2019 ResultsAssertio Therapeutics Announces Strong Second-Quarter 2019 Results
finance.yahoo.com - August 7 at 6:29 PM
Is Assertio Therapeutics (NASDAQ:ASRT) A Risky Investment?Is Assertio Therapeutics (NASDAQ:ASRT) A Risky Investment?
finance.yahoo.com - August 6 at 4:00 PM
 Brokerages Expect Depomed, Inc. (NYSE:ASRT) Will Post Quarterly Sales of $58.49 Million Brokerages Expect Depomed, Inc. (NYSE:ASRT) Will Post Quarterly Sales of $58.49 Million
www.americanbankingnews.com - August 2 at 1:42 AM
$0.22 Earnings Per Share Expected for Depomed, Inc. (NYSE:ASRT) This Quarter$0.22 Earnings Per Share Expected for Depomed, Inc. (NYSE:ASRT) This Quarter
www.americanbankingnews.com - July 31 at 3:12 PM
Assertio (ASRT) Earnings Expected to Grow: Should You Buy?Assertio (ASRT) Earnings Expected to Grow: Should You Buy?
finance.yahoo.com - July 31 at 1:22 PM
Depomed (ASRT) Set to Announce Earnings on WednesdayDepomed (ASRT) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - July 31 at 5:55 AM
ASRT or AMRX: Which Is the Better Value Stock Right Now?ASRT or AMRX: Which Is the Better Value Stock Right Now?
finance.yahoo.com - July 26 at 4:08 PM
Assertio Therapeutics to Report Second Quarter 2019 Financial Results After The Close of Markets on Wednesday, August 7, 2019Assertio Therapeutics to Report Second Quarter 2019 Financial Results After The Close of Markets on Wednesday, August 7, 2019
finance.yahoo.com - July 18 at 12:16 PM
Here’s What Hedge Funds Think About Assertio Therapeutics, Inc. (ASRT)Here’s What Hedge Funds Think About Assertio Therapeutics, Inc. (ASRT)
finance.yahoo.com - June 24 at 2:45 PM
Have Insiders Been Buying Assertio Therapeutics, Inc. (NASDAQ:ASRT) Shares?Have Insiders Been Buying Assertio Therapeutics, Inc. (NASDAQ:ASRT) Shares?
finance.yahoo.com - June 22 at 11:31 AM
ASSERTIO THERAPEUTICS Enters Oversold TerritoryASSERTIO THERAPEUTICS Enters Oversold Territory
finance.yahoo.com - May 20 at 1:25 PM
Is ASSERTIO THERAPEUTICS, INC (ASRT) Stock Outpacing Its Medical Peers This Year?Is ASSERTIO THERAPEUTICS, INC (ASRT) Stock Outpacing Its Medical Peers This Year?
finance.yahoo.com - May 14 at 10:31 AM
Assertio Therapeutics Announces First-Quarter 2019 Financial ResultsAssertio Therapeutics Announces First-Quarter 2019 Financial Results
finance.yahoo.com - May 9 at 12:08 PM
Assertio: 1Q Earnings SnapshotAssertio: 1Q Earnings Snapshot
finance.yahoo.com - May 9 at 12:08 PM
Assertio (ASRT) Tops Q1 Earnings and Revenue EstimatesAssertio (ASRT) Tops Q1 Earnings and Revenue Estimates
finance.yahoo.com - May 9 at 12:08 PM
Assertio Therapeutics, Inc (ASRT) Q1 2019 Earnings Call TranscriptAssertio Therapeutics, Inc (ASRT) Q1 2019 Earnings Call Transcript
finance.yahoo.com - May 9 at 12:08 PM
Assertio Therapeutics (ASRT) to Post Q1 Earnings: What's Up?Assertio Therapeutics (ASRT) to Post Q1 Earnings: What's Up?
finance.yahoo.com - May 6 at 3:49 PM
Analysts Estimate Assertio (ASRT) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate Assertio (ASRT) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - May 1 at 11:43 AM
Assertio Therapeutics to Report First Quarter 2019 Financial Results After The Close of Markets on Wednesday, May 8, 2019Assertio Therapeutics to Report First Quarter 2019 Financial Results After The Close of Markets on Wednesday, May 8, 2019
finance.yahoo.com - April 25 at 11:58 AM
What Assertio Therapeutics, Inc.'s (NASDAQ:ASRT) ROE Can Tell UsWhat Assertio Therapeutics, Inc.'s (NASDAQ:ASRT) ROE Can Tell Us
finance.yahoo.com - April 23 at 11:40 AM
Assertio Therapeutics Announces Appointment of Jay Galeota to Board of DirectorsAssertio Therapeutics Announces Appointment of Jay Galeota to Board of Directors
finance.yahoo.com - April 1 at 12:34 PM
Assertio Therapeutics Announces Favorable NUCYNTA® Patent RulingAssertio Therapeutics Announces Favorable NUCYNTA® Patent Ruling
finance.yahoo.com - March 28 at 3:53 PM
Assertio Therapeutics Inc (ASRT) Files 10-K for the Fiscal Year Ended on December 31, 2018Assertio Therapeutics Inc (ASRT) Files 10-K for the Fiscal Year Ended on December 31, 2018
finance.yahoo.com - March 11 at 3:45 PM
Assertio Therapeutics to Report Fourth Quarter and Full Year 2018 Financial Results After The Close of Markets on Wednesday, March 6, 2019Assertio Therapeutics to Report Fourth Quarter and Full Year 2018 Financial Results After The Close of Markets on Wednesday, March 6, 2019
finance.yahoo.com - February 22 at 11:26 AM
Assertio Therapeutics Announces Appointment of Heather L. Mason to Board of DirectorsAssertio Therapeutics Announces Appointment of Heather L. Mason to Board of Directors
finance.yahoo.com - February 19 at 11:06 AM
Assertio Therapeutics Announces FDA Notification of Acceptance for Filing of 505(b)(2) NDA for Long-acting CosyntropinAssertio Therapeutics Announces FDA Notification of Acceptance for Filing of 505(b)(2) NDA for Long-acting Cosyntropin
finance.yahoo.com - February 19 at 11:06 AM
ASRT or COLL: Which Is the Better Value Stock Right Now?ASRT or COLL: Which Is the Better Value Stock Right Now?
finance.yahoo.com - February 15 at 11:19 AM
Assertio Therapeutics Announces Submission of NDA for FDA Approval of Cosyntropin DepotAssertio Therapeutics Announces Submission of NDA for FDA Approval of Cosyntropin Depot
finance.yahoo.com - December 20 at 9:10 AM
Should You Be Concerned About Assertio Therapeutics Inc’s (NASDAQ:ASRT) Historical Volatility?Should You Be Concerned About Assertio Therapeutics Inc’s (NASDAQ:ASRT) Historical Volatility?
finance.yahoo.com - November 14 at 7:39 AM
Assertio: 3Q Earnings SnapshotAssertio: 3Q Earnings Snapshot
finance.yahoo.com - November 9 at 7:28 AM
Assertio Therapeutics Announces the Appointment of Daniel A. Peisert as Senior Vice President and Chief Financial Officer; Current CFO Phil B. Donenberg to Retire November 30, 2018Assertio Therapeutics Announces the Appointment of Daniel A. Peisert as Senior Vice President and Chief Financial Officer; Current CFO Phil B. Donenberg to Retire November 30, 2018
finance.yahoo.com - October 30 at 7:13 AM
Opioid antidote inventor: We're in the 'next phase of this opioid crisis'Opioid antidote inventor: We're in the 'next phase of this opioid crisis'
finance.yahoo.com - October 11 at 3:17 PM
Assertio Therapeutics to Report Third-Quarter 2018 Financial Results After The Close of Markets on Thursday, November 8, 2018Assertio Therapeutics to Report Third-Quarter 2018 Financial Results After The Close of Markets on Thursday, November 8, 2018
finance.yahoo.com - October 8 at 3:17 PM
Healthcare Industry Trends And Its Impact On Assertio Therapeutics Inc (NASDAQ:ASRT)Healthcare Industry Trends And Its Impact On Assertio Therapeutics Inc (NASDAQ:ASRT)
finance.yahoo.com - September 13 at 3:15 PM
See what the IHS Markit Score report has to say about Assertio Therapeutics Inc.See what the IHS Markit Score report has to say about Assertio Therapeutics Inc.
finance.yahoo.com - September 6 at 3:15 PM
Assertio Therapeutics to Present at the 16th Annual Morgan Stanley Global Healthcare ConferenceAssertio Therapeutics to Present at the 16th Annual Morgan Stanley Global Healthcare Conference
finance.yahoo.com - September 5 at 3:15 PM
ASRT, Purdue Settle Suit, RCUS For The Long Haul, IRMD Sees Bright Days AheadASRT, Purdue Settle Suit, RCUS For The Long Haul, IRMD Sees Bright Days Ahead
www.nasdaq.com - August 30 at 5:15 AM
Heres Why Assertio Therapeutics Inc. Dropped as Much as 18.6% TodayHere's Why Assertio Therapeutics Inc. Dropped as Much as 18.6% Today
www.fool.com - August 29 at 3:15 PM
Assertio Therapeutics and Purdue Pharma Settle Patent Infringement LawsuitAssertio Therapeutics and Purdue Pharma Settle Patent Infringement Lawsuit
finance.yahoo.com - August 29 at 5:31 AM
This page was last updated on 8/24/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel